~6m&I6c&

ow ;Lr FR+FBY=B2 K vuvbJu*b Xs/vIvCI/X *| M0{0r \Z0^ bn4[[ Qj!TCi!TQ 5sf H@/@_{@/J{ @bA;)N^;UN M}# &iX&ij. l3(~3*3 U; +gY` A[gF,ct DB $C2qv2 oHd:?EE@?HE [4hjUx4O[ $Y!QA _F gQEe =3Ws s Z\{K6K`1g6 TV0 x0e;S*w @[N:n* R= A|5AcU !AX;KuX[.

rDTFD-Q|
y3rdRrd 17*: tr |LELX-vG
/GC6O
unczQL^dU
uBV}f*y}NBK
4zm+3t -K& `7R57=7M )V[)yQ
h10EZkZvJ$
uBV}f*y}NBK
zyIuPHau2 CrC i=9*== A*b*I*6I*8b 344X^X4XmkA
h10EZkZvJ$
uBV}f*y}NBK
dj1Fj
h10EZkZvJ$
uBV}f*y}NBK
Cn ]p_p
h10EZkZvJ$
uBV}f*y}NBK
+{[KK[K-{- ^$n$\$-\$vn Negc}cgcgjn
h10EZkZvJ$
uBV}f*y}NBK
]JkJx]x JHIH~HF~HKI 7U:/-/:/h5&
h10EZkZvJ$
uBV}f*y}NBK
!Xu N#\#
h10EZkZvJ$
uBV}f*y}NBK
oX _A= (3#Z_@ /_ZW
h10EZkZvJ$
uBV}f*y}NBK
~jnp1Z%j $QD[|D/ y!vyOj
h10EZkZvJ$
uBV}f*y}NBK
qFN}M 5vYS|(
h10EZkZvJ$
uBV}f*y}NBK
qFN}M 5vYS|(
h10EZkZvJ$
uBV}f*y}NBK
qFN}M 5vYS|(
h10EZkZvJ$
uBV}f*y}NBK
qFN}M 5vYS|(
h10EZkZvJ$
uBV}f*y}NBK
qFN}M 5vYS|(
h10EZkZvJ$
uBV}f*y}NBK
qFN}M 5vYS|(
h10EZkZvJ$
uBV}f*y}NBK
9oM469M4X yUU/ ~V
h10EZkZvJ$
uBV}f*y}NBK
f2 1GaCy FEb
h10EZkZvJ$
uBV}f*y}NBK
]} 0\S6( \?c
h10EZkZvJ$
uBV}f*y}NBK
Ux !XoO& /8,l],
h10EZkZvJ$
uBV}f*y}NBK
{! }{}|}ᵃ
h10EZkZvJ$
uBV}f*y}NBK
tlQA;iW o#SBSᵃ
h10EZkZvJ$
uBV}f*y}NBK
(:@ *)TgTᵃ
h10EZkZvJ$
uBV}f*y}NBK
)] 3YX||ᵃ
h10EZkZvJ$
uBV}f*y}NBK
)W g;())
h10EZkZvJ$
uBV}f*y}NBK
YiibO!O
h10EZkZvJ$
uBV}f*y}NBK
FG hsMM
h10EZkZvJ$
uBV}f*y}NBK
AT 6EH cIZf/ 3=Zuv8
h10EZkZvJ$
uBV}f*y}NBK
AT 6EH cIZf/ 3=Zuv8
h10EZkZvJ$
uBV}f*y}NBK
AT 6EH cIZf/ 3=Zuv8
h10EZkZvJ$
uBV}f*y}NBK
HM QMj3r WiZW 8@J^J
h10EZkZvJ$
uBV}f*y}NBK
qFN}M 5vYS|(
h10EZkZvJ$
uBV}f*y}NBK
,q $$#pm ?6]H]V Hu ,U. mCEnE1 e=SA !zi7i
h10EZkZvJ$
uBV}f*y}NBK
{D xJwx-YJ
h10EZkZvJ$
uBV}f*y}NBK
FG hsMM
h10EZkZvJ$
uBV}f*y}NBK
nx `WGG
h10EZkZvJ$
uBV}f*y}NBK
{n \AK
h10EZkZvJ$
uBV}f*y}NBK
Un wUU1 E,:O }ll
h10EZkZvJ$
uBV}f*y}NBK
j+ ^;$
h10EZkZvJ$
uBV}f*y}NBK
kg h`--
h10EZkZvJ$
uBV}f*y}NBK
@v$\{Hc QcP|P
h10EZkZvJ$
uBV}f*y}NBK
TE fb#bUBU
h10EZkZvJ$
uBV}f*y}NBK
$d\q\ roEg^E9:dREEo _mWdlY6)0m=^
h10EZkZvJ$
uBV}f*y}NBK
VfV 4|;k|
h10EZkZvJ$
uBV}f*y}NBK
=U= -xp
h10EZkZvJ$
uBV}f*y}NBK
j[h-zz =!rc*F!Flc2%
h10EZkZvJ$
uBV}f*y}NBK
uK3H88 Yv;o`zvzNo]Y
h10EZkZvJ$
uBV}f*y}NBK
6-6 \MU [[f W|W &BB
h10EZkZvJ$
uBV}f*y}NBK
:r }QQᵇ
h10EZkZvJ$
uBV}f*y}NBK
vcv PN
h10EZkZvJ$
uBV}f*y}NBK
FsF $88
h10EZkZvJ$
uBV}f*y}NBK
h}h CqX
h10EZkZvJ$
uBV}f*y}NBK
+=+ 77 KHXU \uWW=WF&
h10EZkZvJ$
uBV}f*y}NBK
vJf,Jb$
h10EZkZvJ$
uBV}f*y}NBK
uK3H88 Yv;o`zvzNo]Y
h10EZkZvJ$
uBV}f*y}NBK
y|9St|* )D),&/xh4, ABSw!YSyNw/
h10EZkZvJ$
uBV}f*y}NBK
e~9~B OHK!F!0!u
h10EZkZvJ$
uBV}f*y}NBK
RbbVVbb
h10EZkZvJ$
uBV}f*y}NBK
nH
h10EZkZvJ$
uBV}f*y}NBK
}_} Q0
h10EZkZvJ$
uBV}f*y}NBK
TuT BV3
h10EZkZvJ$
uBV}f*y}NBK
/o Qj,
h10EZkZvJ$
uBV}f*y}NBK
h}h CqX
h10EZkZvJ$
uBV}f*y}NBK
`t` QJIkJ &-W^ 9vKYt
h10EZkZvJ$
uBV}f*y}NBK
8U32+vZ]WD _^ed_eF KV^W)) O\ow|J\JKw{a
h10EZkZvJ$

[* eX `!N ,P,)

~Ensem collaboration; BeiGene has global rights. ADualityBio collaboration; BeiGene has global rights. ?Leads Biolabs collaboration; BeiGene has ex-China commercial rights. MMay include anti-PD-1, anti-LAG3, anti-OX40, and HPK1 inhibitor. HZymeworks/Jazz collaboration; BeiGene has APAC/ex Japan, AU, and NZ commercial rights. WAmgen collaboration; BeiGene has China commercial rights. JLuye collaboration; BeiGene has China rights. D in combination with Zanubrutinib.

Please login or register for full access

Register

Already registered?  Login